Development of a cell culture assay for the quantitative determination of vaccination-induced antibodies in rabbit sera against Clostridium perfringens epsilon toxin and Clostridium novyi alpha toxin

Veterinary Microbiology

Volumn 114, Issue 1-2, 2006, Pages 41-50

  Borrmann, E ^a   Schulze, F ^a   Cussler, K ^b   Hanel I ^a   Diller, R ^a  

^a FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^b PAUL EHRLICH INSTITUT   (Germany)

Author keywords

Alpha toxin; C. novyi type B; C. perfringens type D; Cell culture assay; Clostridial vaccines; Epsilon toxin; Potency test

Indexed keywords

ANTIBODY; BACTERIAL TOXIN; VACCINE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL STRAIN; CLOSTRIDIUM PERFRINGENS; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; MEDICAL LITERATURE; NONHUMAN; QUANTITATIVE ANALYSIS; RABBIT; SERODIAGNOSIS; VACCINATION; VERO CELL;

ANIMAL TESTING ALTERNATIVES; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL TOXINS; BACTERIAL VACCINES; CELL LINE; CERCOPITHECUS AETHIOPS; CLOSTRIDIUM; DOGS; IMMUNE SERA; IMMUNOASSAY; KIDNEY; RABBITS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STATISTICS; STATISTICS AS TOPIC; VERO CELLS;

ANIMALIA; BACTERIA (MICROORGANISMS); CLOSTRIDIUM NOVYI; CLOSTRIDIUM PERFRINGENS; ORYCTOLAGUS CUNICULUS;

EID: 33645233829     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2005.10.043     Document Type: Article

References (36)

1. K. Amimoto, O. Sasaki, M. Isogai, T. Kitajima, E. Oishi, N. Okada, and H. Yasuhara The protective effect of C. novyi alpha-toxoid against challenge with spores in guinea pigs J. Vet. Med. Sci. (Jpn.) 60 1998 681 685
2. D.W. Ball, R.L.V. Tassell, H.D. Roberts, P.E. Hahn, D.M. Lyerly, and T.D. Wilkins Purification and characterization of alpha-toxin produced by Clostridium novyi type A Infect. Immun. 61 1993 2912 2918
3. Belinga, K., 2001. Entwicklung und Prävalidierung eines Toxininhibitionstestes als Tierversuchsersatz im Rahmen der Prüfung von Immunpräparaten gegen das Alphatoxin von Clostridium novyi type B. Dissertation, Berlin.
4. P. Bette, J. Frevert, F. Mauler, N. Suttorp, and E. Habermann Pharmacological and biochemical studies of cytotoxicity of Clostridium novyi type A alpha-toxin Infect. Immun. 57 1989 2507 2513
5. E. Borrmann, and F. Schulze Use of cell culture assays for potency testing of C. perfringens immunobiologicals as an alternative to mouse toxin neutralization test Pharmeuropa, Special Issue Biol. 1 1997 30 39
6. E. Borrmann, and F. Schulze Detection of Clostridium novyi type B α toxin by cell culture systems FEMS Immun. Med. Microbiol. 24 1999 275 280
7. L. Bruckner Validation of potency tests for veterinary vaccines M. Balls A.-M. van Zeller M. Halder Progress in the Reduction, Refinement and Replacement of Animal Experimentation 2000 Elsevier Amsterdam/New York/Oxford 987 989
8. K. Cußler Tierversuche im Arzneibuch - Möglichkeiten für Alternativen bei Veterinärimpfstoffen H. Schöffl H. Spielmann H.A. Tritthart K. Cußler U. Fuhrmann A.F. Goetschl F.P. Gruber C. Heusser H. Möller H. Ronneberger A. Vedani Forschung ohne Tierversuche 1995 Springer Publishing House Vienna/New York 184 187
9. B. Dawson-Saunders, and R.G. Trapp Basic and Clinical Biostatistics 1990 Appleton & Lange Norwalk p. 56
10. G. Donelli, and C. Fiorentini Bacterial protein toxins acting on the cell cytoskeleton Microbiologica 17 1994 345 362
11. Ebert, E., 1998. Gesetzlich vorgeschriebene Tierversuche zur Wirksamkeitsprüfung von Clostridium perfringens -Immunpräparaten: Entwicklung und Prävalidierung von Alternativmethoden. Dissertation, Frankfurt/Main.
12. E. Ebert, M. Kusch, V. Öppling, E. Werner, and K. Cußler Serologische Wirksamkeitsprüfung von Clostridium perfringens Impfstoffen Alternativen zu Tierexperimenten 13 1996 68 75
13. E. Ebert, V. Oeppling, E. Werner, and K. Cußler Development and prevalidation of two different ELISA systems for the potency testing of Clostridium perfringens β- and ε-toxoid containing veterinary vaccines FEMS Immun. Med. Microbiol. 24 1999 299 311
14. European Pharmacopoeia, 2002. fourth ed. Council of Europe, Strassbourg.
15. L. Fahrmeir, R. Künstler, I. Pigeot, and G. Tutz Statistik, Der Weg zur Datenanalyse 2001 Springer-Verlag Berlin/Heidelberg/New York p. 139
16. C.F.M. Hendriksen Animal experimentation and the concept of alternatives C.F.M. Hendriksen H.B.W.M. Koeter Animals in Biomedical Research 1991 Elsevier Amsterdam/New York/Oxford 1 16
17. C. Hendriksen, J.-M. Spieser, A. Akkermans, M. Balls, L. Bruckner, K. Cußler, A. Daas, J. Descamps, R. Dobbelaer, J. Fentem, M. Halder, M. v.d. Kamp, R. Lucken, J. Milstein, D. Sesardic, D. Straughan, and A. Valadares Validation of alternative methods for the potency testing of vaccines ATLA 26 1998 747 761
18. I. Just, and R. Gerhard Large clostridial cytotoxins Rev. Physiol. Biochem. Pharmacol. 152 2004 23 47
19. M. Kanoe, Y. Masui, Y. Murakami, and Y. Yaguchi Detection of cytotoxic effects of Clostridium novyi type A on bovine kidney cells Microbios 95 1998 7 13
20. P.A. Knight, C. Burnett, A.M. Whitaker, and J. Queminet The titration of clostridial toxoids and antisera in cell culture Develop. Biol. Standard. 64 1986 129 136
21. P.A. Knight, J. Queminet, J.H. Blanchard, and J.H. Tilleray In vitro tests for the measurements of clostridial toxins, toxoids and antisera. II. Titration of Clostridium perfringens toxins and antitoxins in cell culture Biologicals 18 1990 263 270
22. C.D. Lindsay Assessment of aspects of the toxicity of Clostridium perfringens epsilon toxin using the MDCK cell line Hum. Exp. Toxicol. 15 1996 904 908
23. N.J. Marshall, C.J. Goodwin, and S.J. Holt A critical assessment of the use of microculture tetrazolium assays to measure cell growth and function Growth Regul. 5 1995 69 84
24. T. Mossmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Methods 65 1983 55 63
25. H. Müller, Ch. v. Eichel-Streiber, and E. Habermann Morphological changes of cultured endothelial cells after microinjection of toxins that act on the cytoskeleton Infect. Immun. 60 1992 2007 3010
26. G. Müller, H. Rosner, B. Rohrmann, W. Erler, G. Geschwend, U. Gräfe, B. Burkert, U. Möller, R. Diller, K. Sachse, and H. Köhler Effects of the mycotoxin ochatoxin A and some of ist metabolites on the human cell line THP-1 Toxicology 184 2003 69 82
27. D.W. Payne, E.D. Williamson, H. Havard, N. Modi, and J. Brown Evaluation of a new cytotoxicity assay for Clostridium perfringens type D epsilon toxin FEMS Microbiol. Lett. 116 1994 161 168
28. L. Petit, M. Gibert, D. Gillet, C. Laurent-Winter, P. Boquet, and M.R. Popoff Clostridium perfringens epsilon toxin acts on MDCK cells by forming a large membrane complex J. Bacteriol. 179 1997 6480 6487
29. L. Petit, E. Maier, M. Gibert, M.R. Popoff, and R. Benz Clostridium perfringens epsilon toxin induces a rapid change of cell membrane permeability to ions and forms channels in artificial lipid bilayers J. Biol. Chem. 276 2001 15736 15740
30. L. Petit, M. Gibert, A. Gourch, M. Bens, A. Vandewalle, and M.R. Popoff Clostridium perfringens epsilon toxin rapidly decreases membrane barrier permeability of polarized MDCK cells Cell. Microbiol. 5 2003 155 164
31. U. Rosskopf-Streicher, P. Volkers, and E. Werner Control of Clostridium perfringens vaccines using an indirect competitive ELISA for the epsilon toxin component Pharmeuropa Special Issue Biol. 2 2003 91 96
32. U. Rosskopf-Streicher, P. Volkers, K. Noeske, and E. Werner Quality assurance of C. perfringens epsilon toxoid vaccines-ELISA versus mouse neutralisation test Alternativen zu Tierexperimenten 21 Suppl. 2004 65 69
33. J. Selzer, F. Hofmann, G. Rex, M. Wilm, M. Mann, I. Just, and K. Aktories Clostridium novyi α-toxin-catalyzed incorporation of GlcNAc into RHO subfamily proteins J. Biol. Chem. 271 1996 25173 25177
34. S.J. Shortt, R.W. Titball, and C.D. Lindsay An assessment of the in vitro toxicology of Clostridium perfringens type D ε-toxin in human and animal cells Hum. Exp. Toxicol. 19 2000 108 116
35. J.G. Smedley, D.J. Fisher, S. Sayeed, G. Chakrabarti, and B.A. McClane The enteric toxins of Clostridium perfringens Rev. Physiol. Biochem. Pharmacol. 152 2004 183 204
36. K. Weißer, and U. Hechler Animal welfare aspects in the quality control of immunobiologicals. A critical evaluation of the animal tests in Pharmacopoeia Monographs 1997 FRAME Nottingham